Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer

Biomedicine and Pharmacotherapy

Volumn 70, Issue C, 2015, Pages 72-79

  Yao, Shihua ^a   Zhao, Tiejun ^a   Jin, Hai ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

HMGB1; Invasion; MiR 325 3p; NSCLC; Prognosis; Proliferation

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA; MICRORNA 325 3P; UNCLASSIFIED DRUG; HMGB1 PROTEIN, HUMAN; MIRN325 MICRORNA, HUMAN; SMALL INTERFERING RNA;

ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; LUNG CANCER CELL LINE; LYMPH NODE METASTASIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; TUMOR INVASION; UPREGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING;

EID: 84927520862     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.01.013     Document Type: Article

References (26)

1. Sanchez de Cos J., Sojo Gonzalez M.A., Montero M.V., Perez Calvo M.C., Vicente M.J., Valle M.H. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors. Lung Cancer 2009, 63:140-145.
2. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
3. Fabbri M. miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn 2010, 10:435-444.
4. Baranwal S., Alahari S.K. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010, 126:1283-1290.
5. Wang R., Wang Z.X., Yang J.S., Pan X., De W., Chen L.B. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011, 30:2644-2658.
6. Bian H.B., Pan X., Yang J.S., Wang Z.X., De W. Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res 2011, 30:20.
7. Su J., Wang Q., Liu Y., Zhong M. miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3. Mol Cell Biochem 2014, 392:289-296.
8. Xiao J., Ding Y., Huang J., Li Q., Liu Y., Ni W., et al. The association of HMGB1 gene with the prognosis of HCC. PLoS One 2014, 9:e89097.
9. Suren D., Yildirim M., Demirpence O., Kaya V., Alikanoglu A.S., Bulbuller N., et al. The role of high mobility group box 1 (HMGB1) in colorectal cancer. Med Sci Monit 2014, 20:530-537.
10. Zhang J., Kou Y.B., Zhu J.S., Chen W.X., Li S. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-kappaB pathway in vitro and in vivo. Int J Oncol 2014, 44:1268-1276.
11. Dykxhoorn D.M. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 2010, 70:6401-6406.
12. Hummel R., Hussey D.J., Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010, 46:298-311.
13. Kang I.H., Jeong B.C., Hur S.W., Choi H., Choi S.H., Ryu J.H., et al. MicroRNA-302a stimulates osteoblastic differentiation by repressing COUP-TFII Expression. J Cell Physiol 2014, 230:911-921.
14. Price N.L., Ramirez C.M., Fernandez-Hernando C. Relevance of microRNA in metabolic diseases. Crit Rev Clin Lab Sci 2014, 1-16.
15. Du B., Wang Z., Zhang X., Feng S., Wang G., He J., et al. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells. PLoS One 2014, 9:e88022.
16. Wang L.L., Du L.T., Li J., Liu Y.M., Qu A.L., Yang Y.M., et al. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. World J Gastroenterol 2014, 20:11340-11346.
17. Kim M.K., Jung S.B., Kim J.S., Roh M.S., Lee J.H., Lee E.H., et al. Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. Virchows Arch 2014, 465:463-471.
18. Wang T.Y., Liu S.G., Zhao B.S., Qi B., Qin X.G., Yao W.J. Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis. Genet Mol Res 2014, 13:5574-5581.
19. Xu F., Zhang H., Su Y., Kong J., Yu H., Qian B. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers. Clin Transl Oncol 2014, 16:980-985.
20. Zhang J., Xu L., Yang Z., Lu H., Hu D., Li W., et al. MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin. Clin Transl Oncol 2014.
21. Alexandrova E.A., Beltchev B.G. Acetylated HMG1 protein interacts specifically with homologous DNA polymerase alpha in vitro. Biochem Biophys Res Commun 1988, 154:918-927.
22. Ohmori H., Luo Y., Kuniyasu H. Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer. Expert Opin Ther Targets 2011, 15:183-193.
23. Shen X., Hong L., Sun H., Shi M., Song Y. The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer. Oncol Rep 2009, 22:535-539.
24. Liu F., Zhang Y., Peng Z., Gao H., Xu L., Chen M. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. J Transl Med 2012, 10:135.
25. Chuangui C., Peng T., Zhentao Y. The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Pathol Oncol Res 2012, 18:1021-1027.
26. Liu Y., Xie C., Zhang X., Huang D., Zhou X., Tan P., et al. Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance. Eur J Cancer 2010, 46:3007-3015.